|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Diamandis P and Aldape KD: Insights from
molecular profiling of adult glioma. J Clin Oncol. 35:2386–2393.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Laug D, Glasgow SM and Deneen B: A glial
blueprint for gliomagenesis. Nat Rev Neurosci. 19:393–403. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao J, Li H, Zhao S, Wang E, Zhu J, Feng
D, Zhu Y, Dou W, Fan Q, Hu J, et al: Epigenetic silencing of
miR-144/451a cluster contributes to HCC progression via paracrine
HGF/MIF-mediated TAM remodeling. Mol Cancer. 20:462021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li SZ, Ren KX, Zhao J, Wu S, Li J, Zang J,
Fei Z and Zhao JL: miR-139/PDE2A-Notch1 feedback circuit represses
stemness of gliomas by inhibiting Wnt/β-catenin signaling. Int J
Biol Sci. 17:3508–3521. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu Q, Luo X, Terp MG, Li Q, Li Y, Shen L,
Chen Y, Jacobsen K, Bivona TG, Chen H, et al: DDX56 modulates
post-transcriptional Wnt signaling through miRNAs and is associated
with early recurrence in squamous cell lung carcinoma. Mol Cancer.
20:1082021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Godlewski J, Krichevsky AM, Johnson MD,
Chiocca EA and Bronisz A: Belonging to a network-microRNAs,
extracellular vesicles, and the glioblastoma microenvironment.
Neuro Oncol. 17:652–662. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen X, Liang H, Zhang J, Zen K and Zhang
CY: Secreted microRNAs: A new form of intercellular communication.
Trends Cell Biol. 22:125–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hassan A, Mosley J, Singh S and Zinn PO: A
comprehensive review of genomics and noncoding RNA in gliomas. Top
Magn Reson Imaging. 26:3–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peng Z, Zhu Y, Zhang Y, Wilhelmsen K, Jia
C, Jin J, Xue Q, Feng X, Zhang F and Yu B: Effects of ghrelin on
pulmonary NOD2 mRNA expression and NF-κB activation when protects
against acute lung injury in rats challenged with cecal ligation
and puncture. Int Immunopharmacol. 13:440–445. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan Q, Zhao P, Li J, Xie X, Xu M, Zhang Y,
Mu D, Li W, Sun R, Liu W, et al: 17β-Estradiol administration
attenuates seawater aspiration-induced acute lung injury in rats.
Pulm Pharmacol Ther. 24:673–681. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qiu YB, Wan BB, Liu G, Wu YX, Chen D, Lu
MD, Chen JL, Yu RQ, Chen DZ and Pang QF: Nrf2 protects against
seawater drowning-induced acute lung injury via inhibiting
ferroptosis. Respir Res. 21:2322020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Buntwal L, Sassi M, Morgan AH, Andrews ZB
and Davies JS: Ghrelin-mediated hippocampal neurogenesis:
Implications for health and disease. Trends Endocrinol Metab.
30:844–859. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Menigatti M, Staiano T, Manser CN,
Bauerfeind P, Komljenovic A, Robinson M, Jiricny J, Buffoli F and
Marra G: Epigenetic silencing of monoallelically methylated miRNA
loci in precancerous colorectal lesions. Oncogenesis. 2:e562013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie Y, Wei RR, Huang GL, Zhang MY, Yuan YF
and Wang HY: Checkpoint kinase 1 is negatively regulated by miR-497
in hepatocellular carcinoma. Med Oncolo. 31:8442014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang J, Ye Z, Mei D, Gu H and Zhang J:
Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating
miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer.
Cancer Manag Res. 11:4209–4221. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Özata DM, Caramuta S, Velázquez-Fernández
D, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C and
Lui WO: The role of microRNA deregulation in the pathogenesis of
adrenocortical carcinoma. Endocr Relat Cancer. 18:643–655. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei Z, Hu X, Liu J, Zhu W, Zhan X and Sun
S: MicroRNA-497 upregulation inhibits cell invasion and metastasis
in T24 and BIU-87 bladder cancer cells. Mol Med Rep. 16:2055–2060.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sen LS, Karakoyun B, Yeğen C, Akkiprik M,
Yüksel M, Ercan F, Özer A and Yeğen BÇ: Treatment with either
obestatin or ghrelin attenuates mesenteric
ischemia-reperfusion-induced oxidative injury of the ileum and the
remote organ lung. Peptides. 71:8–19. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo M, Shen D, Zhou X, Chen X and Wang W:
MicroRNA-497 is a potential prognostic marker in human cervical
cancer and functions as a tumor suppressor by targeting the
insulin-like growth factor 1 receptor. Surgery. 153:836–847. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maura F, Cutrona G, Mosca L, Matis S,
Lionetti M, Fabris S, Agnelli L, Colombo M, Massucco C, Ferracin M,
et al: Association between gene and miRNA expression profiles and
stereotyped subset #4 B-cell receptor in chronic lymphocytic
leukemia. Leuk Lymphoma. 56:3150–3158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Troppan K, Wenzl K, Pichler M, Pursche B,
Schwarzenbacher D, Feichtinger J, Thallinger GG, Beham-Schmid C,
Neumeister P and Deutsch A: miR-199a and miR-497 are associated
with better overall survival due to increased chemosensitivity in
diffuse large B-cell lymphoma patients. Int J Mol Sci.
16:18077–18095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matthay MA, McAuley DF and Ware LB:
Clinical trials in acute respiratory distress syndrome: Challenges
and opportunities. Lancet Respir Med. 5:524–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang J, Yang FJ, Wang YG, Su GF and Miao
X: LncRNA MIR497HG inhibits proliferation and migration of retinal
endothelial cells under high-level glucose treatment via
miRNA-128-3p/SIRT1 axis. Eur Rev Med Pharmacol Sci. 24:5871–5877.
2020.PubMed/NCBI
|
|
26
|
Zhuang C, Liu Y, Fu S, Yuan C, Luo J,
Huang X, Yang W, Xie W and Zhuang C: Silencing of lncRNA MIR497HG
via CRISPR/Cas13d induces bladder cancer progression through
promoting the crosstalk between Hippo/Yap and TGF-β/Smad signaling.
Front Mol Biosci. 7:6167682020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ganini C, Amelio I, Bertolo R, Bove P,
Buonomo OC, Candi E, Cipriani C, Di Daniele N, Juhl H, Mauriello A,
et al: Global mapping of cancers: The cancer genome atlas and
beyond. Mol Oncol. Jul 10–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bayne K: Revised guide for the care and
use of laboratory animals available. American Physiological
Society. Physiologist. 39:199, 208–211. 1996.PubMed/NCBI
|
|
30
|
Wang H, Yan X, Ji LY, Ji XT, Wang P, Guo
SW and Li SZ: miR-139 Functions as an antioncomir to repress glioma
progression through targeting IGF-1 R, AMY-1, and PGC-1β. Technol
Cancer Res Treat. 16:497–511. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peterson SM, Thompson JA, Ufkin ML,
Sathyanarayana P, Liaw L and Congdon CB: Common features of
microRNA target prediction tools. Front Genet. 5:232014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Riffo-Campos AL, Riquelme I and
Brebi-Mieville P: Tools for sequence-based miRNA Target Prediction:
What to Choose? Int J Mol Sci. 17:19872016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chae DK, Park J, Cho M, Ban E, Jang M, Yoo
YS, Kim EE, Baik JH and Song EJ: MiR-195 and miR-497 suppress
tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-β
receptor I ubiquitination. Mol Oncol. 13:2663–2678. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feng L, Cheng K, Zang R, Wang Q and Wang
J: miR-497-5p inhibits gastric cancer cell proliferation and growth
through targeting PDK3. Biosci Rep. 39:BSR201906542019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hassan N, Zhao JT, Glover A, Robinson BG
and Sidhu SB: Reciprocal interplay of miR-497 and MALAT1 promotes
tumourigenesis of adrenocortical cancer. Endocr Relat Cancer.
26:677–688. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xia Y, Hu C, Lian L, Hui K, Wang L, Qiao
Y, Liu L, Liang L and Jiang X: miR497 suppresses malignant
phenotype in nonsmall cell lung cancer via targeting KDR. Oncol
Rep. 42:443–452. 2019.PubMed/NCBI
|
|
38
|
Yang L, Cai Y, Zhang D, Sun J, Xu C, Zhao
W, Jiang W and Pan C: miR-195/miR-497 Regulate CD274 expression of
immune regulatory ligands in triple-negative breast cancer. J
Breast Cancer. 21:371–381. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Li X, Zhang J and Mao L: E6
hijacks KDM5C/lnc_000231/miR-497-5p/CCNE1 axis to promote cervical
cancer progression. J Cell Mol Med. 24:11422–11433. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Han Z, Zhang Y, Yang Q, Liu B, Wu J, Zhang
Y, Yang C and Jiang Y: miR-497 and miR-34a retard lung cancer
growth by co-inhibiting cyclin E1 (CCNE1). Oncotarget.
6:13149–13163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wei W, Zhang WY, Bai JB, Zhang HX, Zhao
YY, Li XY and Zhao SH: The NF-κB-modulated microRNAs miR-195 and
miR-497 inhibit myoblast proliferation by targeting Igf1r, Insr and
cyclin genes. J Cell Sci. 129:39–50. 2016.PubMed/NCBI
|
|
42
|
Furuta M, Kozaki K, Tanimoto K, Tanaka S,
Arii S, Shimamura T, Niida A, Miyano S and Inazawa J: The
tumor-suppressive miR-497-195 cluster targets multiple cell-cycle
regulators in hepatocellular carcinoma. PLoS One. 8:e601552013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Luo G, He K, Xia Z, Liu S, Liu H and Xiang
G: Regulation of microRNA-497 expression in human cancer. Oncol
Lett. 21:232021.PubMed/NCBI
|
|
44
|
Boldrin E, Gaffo E, Niedermayer A, Boer
JM, Zimmermann M, Weichenhan D, Claus R, Münch V, Sun Q,
Enzenmüller S, et al: MicroRNA-497/195 is tumor-suppressive and
cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.
Blood. Jun 7–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lu F, Ye Y, Zhang H, He X, Sun X, Yao C,
Mao H, He X, Qian C, Wang B, et al: miR-497/Wnt3a/c-jun feedback
loop regulates growth and epithelial-to-mesenchymal transition
phenotype in glioma cells. Int J Biol Macromol. 120:985–991. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Turcan S, Makarov V, Taranda J, Wang Y,
Fabius AWM, Wu W, Zheng Y, El-Amine N, Haddock S, Nanjangud G, et
al: Mutant-IDH1-dependent chromatin state reprogramming,
reversibility, and persistence. Nat Genet. 50:62–72. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Regazzo G, Terrenato I, Spagnuolo M,
Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V,
Carapella C, Piaggio G, et al: A restricted signature of serum
miRNAs distinguishes glioblastoma from lower grade gliomas. J Exp
Clin Cancer Res. 35:1242016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Feng F, Kuai D, Wang H, Li T, Miao W, Liu
Y and Fan Y: Reduced expression of microRNA-497 is associated with
greater angiogenesis and poor prognosis in human gliomas. Hum
Pathol. 58:47–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang C, Wang C, Chen X, Chen S, Zhang Y,
Zhi F, Wang J, Li L, Zhou X, Li N, et al: Identification of seven
serum microRNAs from a genome-wide serum microRNA expression
profile as potential noninvasive biomarkers for malignant
astrocytomas. Int J Cancer. 132:116–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lan J, Xue Y, Chen H, Zhao S, Wu Z, Fang
J, Han C and Lou M: Hypoxia-induced miR-497 decreases glioma cell
sensitivity to TMZ by inhibiting apoptosis. FEBS Lett.
588:3333–3339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhu D, Tu M, Zeng B, Cai L, Zheng W, Su Z
and Yu Z: Up-regulation of miR-497 confers resistance to
temozolomide in human glioma cells by targeting mTOR/Bcl-2. Cancer
Med. 6:452–462. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yang R, Xing L, Zheng X, Sun Y, Wang X and
Chen J: The circRNA circAGFG1 acts as a sponge of miR-195-5p to
promote triple-negative breast cancer progression through
regulating CCNE1 expression. Mol Cancer. 18:42019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shen L, Orillion A and Pili R: Histone
deacetylase inhibitors as immunomodulators in cancer therapeutics.
Epigenomics. 8:415–428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen Y, Zhang J, Gong W, Dai W, Xu X and
Xu S: miR-588 is a prognostic marker in gastric cancer. Aging.
13:2101–2117. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu Z, Mo H, Sun L, Wang L, Chen T, Yao B,
Liu R, Niu Y, Tu K, Xu Q and Yang N: Long noncoding RNA
PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular
carcinoma by activating PI3K/AKT/mTOR signaling pathway. Cancer
Sci. 111:4118–4128. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yu M, Zhang X, Li H, Zhang P and Dong W:
MicroRNA-588 is downregulated and may have prognostic and
functional roles in human breast cancer. Med Sci Monit.
23:5690–5696. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhao N, Lin T, Zhao C, Zhao S, Zhou S and
Li Y: MicroRNA-588 is upregulated in human prostate cancer with
prognostic and functional implications. J Cell Biochem. Oct
5–2017.(Epub ahead of print).
|
|
59
|
Zhou X and Xu M, Guo Y, Ye L, Long L, Wang
H, Tan P and Xu M: MicroRNA-588 regulates invasion, migration and
epithelial-mesenchymal transition via targeting EIF5A2 pathway in
gastric cancer. Cancer Manag Res. 10:5187–5197. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Shan Z, Shakoori A, Bodaghi S, Goldsmith
P, Jin J and Wiest JS: TUSC1, a putative tumor suppressor gene,
reduces tumor cell growth in vitro and tumor growth in vivo. PLoS
One. 8:e661142013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang R, Yu W, Liang G, Jia Z, Chen Z,
Zhao L, Yuan Y, Zhou X, Li D, Shen S, et al: Tumor suppressor
candidate 1 suppresses cell growth and predicts better survival in
glioblastoma. Cell Mol Neurobiol. 37:37–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
